Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1988-08-02
1989-12-05
Brust, Joseph Paul
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514397, 514432, 514456, 544376, 548336, 549 23, 549403, A61K 3135, A61K 3138, C07D31132, C07D33506
Patent
active
048852988
ABSTRACT:
The invention relates to pharmaceutical preparations containing compounds of formula I ##STR1## in which X represents unsubstituted or substituted amino or a quaternary ammonium salt; halogen, free, etherified or esterified hydroxy; free, etherified, esterified or oxidized mercapto; free or functionally modified carboxyl, free or functionally modified sulfo; acyl; nitro; an unsubstituted or substituted hydrocarbon radical or an unsubstituted or substituted heterocyclic radical, Y represents oxygen, sulfur, sulfinyl or sulfonyl but must be oxygen, sulfinyl or sulfonyl, if X is 1H-imidazol-1-yl, and rings A and B are each unsubstituted or substituted; or pharmaceutically acceptable salts of such compounds that contain a salt-forming group, and to novel compounds of formula I. The compounds are useful e.g. for the treatment of diseases of the respiratory tract and of liver diseases. They are prepared by methods known per se.
REFERENCES:
patent: 2727057 (1955-12-01), Park
patent: 3678044 (1972-07-01), Adams
patent: 3772243 (1973-11-01), Adams
patent: 4143139 (1979-03-01), Bindra
patent: 4162162 (1979-07-01), Dueber
patent: 4228177 (1980-10-01), Hoehn
patent: 4235913 (1980-11-01), Johnson
patent: 4241069 (1980-12-01), Buckler
patent: 4382951 (1983-05-01), Grassberger et al.
F. E. Ward et al., J. Med. Chem. 24, 1073 (1981).
L. Reichel et al., Liebigs Ann. Chem 720, 154 (1968).
G. Miklos et al., Acta Pharm. Hung. 40, 233 (1970).
F. Morsingh, Tetrahedron 25 (1969).
T. Szell et al., Chem. Asstr. 73 3618a.
J. Adams, J. Org. Chem. 32 3992 (1967).
B. L. Verma et al., Chem. Abstr 64 14160f.
P. Bennett et al., J. Chem. Soc. Perkin Tr. 1, 1972 1554.
H. Whittmann et al., Monatsh Chem 96 1016 (1965).
L. Reichel et al., Liebigs Ann., Chem. 693,216 (1966).
J. R. Doherty et al., Chem. Ind. (London) (1967) 1641.
T. Szell et al., Can. J. Chem. 46 1571 (1968).
J. R. Doherty et al., Tetrah, Lett (1968) 441.
D. D. Keane et al., J. Org. Chem 35 2286 (1970).
J. J. Beirne et al., Chem. Abstr. 89 14629f.
J. J. Beirne et al., Chem. Abstr. 89, 109020v.
A. Levai et al., Pharmazie 33 378 (1978).
Z. Dinya et al., Chem. Abstr. 91, 131467j.
E. R. David et al., Acta Chim. Acad. Sci Hung 104, 369 (1980).
A. Szollosy et al., Acta Chim. Acad. Sci Hung 112, 343 (1983).
A. Levai et al., Chem. Abstr. 98, 34569f.
G. Toth et al., Org. Magn. Res. 20, 133 (1982).
R. Onoda et al., Chem. Abstr. 85, 5450m.
G. Toth et al., Chem. Abstr. 99, 194937y.
CA 93:95152h (1980), P. Valenti et al.
Shen et al., "The Development of Antiasthmatic Drugs", Part III, ed. D. R. Buckle et al., Butterworth Publishers, Kent, England, 1983, pp. 315-317 and 331-335.
Bull. Chem. Soc. Jap. 52:1735-1737 (1979).
Houben-Weyl, 4th ed., vol. XI/1, pp. 34-53, 205-207.
Helv. Chem. Acta, 54:710-734 (1971).
J. Med. Chem. 24:468-472 (1981).
"Methoden der Organischen Chemie", in Houben-Weyl 4th ed., vol. II/2b, pp. 1449-1529 (1976).
Tetrahedron Letters 32:2603-2605 (1976).
Tetrahedron Letters, p. 1015 (1979).
Synthesis, pp. 535-537, 543 (1976).
J. Org. Chem. 40:526-527 (1975).
J.A.C.S. 98:7868-7869 (1976).
J.A.C.S. 93:1027 (1971).
J. Org. Chem. 43:4248-4250 (1978).
J. Org. Chem. 45:4522-4524 (1980).
J. Org. Chem. 27:1615, 1620 (1962).
Meiji, patent abstract Japan, JA-7214573-R, May 1, 1972.
Meiji, patent abstract Japan, JA-7019299-R, Jul. 2, 1970.
Weitsch, Beneficial Therapeutic Effect of Decreased Blood Hyperviscosity in Patients with Vascular Diseases (6/88).
Brust Joseph Paul
Fishman Irving M.
Howard Mary Sue
Zyma SA
LandOfFree
Pharmaceutical preparations containing flavanone or thioflavanon does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical preparations containing flavanone or thioflavanon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical preparations containing flavanone or thioflavanon will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2034636